Newgenivf Group Limited Stock Alpha and Beta Analysis

NIVF Stock   0.38  0.02  5.56%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as NewGenIvf Group Limited. It also helps investors analyze the systematic and unsystematic risks associated with investing in NewGenIvf Group over a specified time horizon. Remember, high NewGenIvf Group's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to NewGenIvf Group's market risk premium analysis include:
Beta
(3.62)
Alpha
1.02
Risk
23.32
Sharpe Ratio
0.0299
Expected Return
0.7
Please note that although NewGenIvf Group alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, NewGenIvf Group did 1.02  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of NewGenIvf Group Limited stock's relative risk over its benchmark. NewGenIvf Group has a beta of 3.62  . As returns on the market increase, returns on owning NewGenIvf Group are expected to decrease by larger amounts. On the other hand, during market turmoil, NewGenIvf Group is expected to outperform it. At this time, NewGenIvf Group's Enterprise Value Multiple is most likely to decrease significantly in the upcoming years. The NewGenIvf Group's current Price Fair Value is estimated to increase to 3.99, while Book Value Per Share is projected to decrease to 0.07.

Enterprise Value

87.84 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out NewGenIvf Group Backtesting, NewGenIvf Group Valuation, NewGenIvf Group Correlation, NewGenIvf Group Hype Analysis, NewGenIvf Group Volatility, NewGenIvf Group History and analyze NewGenIvf Group Performance.

NewGenIvf Group Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. NewGenIvf Group market risk premium is the additional return an investor will receive from holding NewGenIvf Group long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NewGenIvf Group. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate NewGenIvf Group's performance over market.
α1.02   β-3.62

NewGenIvf Group expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of NewGenIvf Group's Buy-and-hold return. Our buy-and-hold chart shows how NewGenIvf Group performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

NewGenIvf Group Market Price Analysis

Market price analysis indicators help investors to evaluate how NewGenIvf Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NewGenIvf Group shares will generate the highest return on investment. By understating and applying NewGenIvf Group stock market price indicators, traders can identify NewGenIvf Group position entry and exit signals to maximize returns.

NewGenIvf Group Return and Market Media

The median price of NewGenIvf Group for the period between Sat, Sep 14, 2024 and Fri, Dec 13, 2024 is 0.67 with a coefficient of variation of 38.9. The daily time series for the period is distributed with a sample standard deviation of 0.27, arithmetic mean of 0.69, and mean deviation of 0.18. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price
10/14/2024
2
NewGenIvf Enters into a Binding Term Sheet with White Lion Capital for 100 Million Equity Line ...
11/18/2024
3
NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path ...
11/22/2024
4
NewGen Signs Binding Term Sheet for Reverse Merger with European Wellness Investment Holdings
12/11/2024

About NewGenIvf Group Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including NewGenIvf or other stocks. Alpha measures the amount that position in NewGenIvf Group has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2010 2022 2023 2024 (projected)
Payables Turnover65.9242.1120.0119.01
Days Of Inventory On Hand4.873.8913.3414.01
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NewGenIvf Group in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NewGenIvf Group's short interest history, or implied volatility extrapolated from NewGenIvf Group options trading.

Build Portfolio with NewGenIvf Group

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether NewGenIvf Group is a strong investment it is important to analyze NewGenIvf Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NewGenIvf Group's future performance. For an informed investment choice regarding NewGenIvf Stock, refer to the following important reports:
NewGenIvf Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of NewGenIvf Group technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NewGenIvf Group trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...